Last Updated: June 26, 2026

PROTRIPTYLINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Protriptyline

A generic version of PROTRIPTYLINE was approved as protriptyline hydrochloride by SIGMAPHARM LABS LLC on May 3rd, 2010.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for PROTRIPTYLINE?
  • What are the global sales for PROTRIPTYLINE?
  • What is Average Wholesale Price for PROTRIPTYLINE?
Summary for PROTRIPTYLINE
US Patents:0
Applicants:3
NDAs:3
Drug Prices: Drug price information for PROTRIPTYLINE
DailyMed Link:PROTRIPTYLINE at DailyMed
Drug patent expirations by year for PROTRIPTYLINE
Drug Prices for PROTRIPTYLINE

See drug prices for PROTRIPTYLINE

US Patents and Regulatory Information for PROTRIPTYLINE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 202220-001 Nov 19, 2012 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913-002 Sep 16, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 202220-002 Nov 19, 2012 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913-001 Sep 16, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sigmapharm Labs Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 090462-002 May 3, 2010 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sigmapharm Labs Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 090462-001 May 3, 2010 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links